Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Feb 26, 2018

16-Year Veteran Director Wendy Cameron to Retire from Mylan N.V. Board after 2018 AGM

Feb 20, 2018

Mylan Receives Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program

Feb 08, 2018

Mylan to Release 2017 Fourth Quarter and Full Year Results and 2018 Guidance on Feb. 28, 2018

Feb 01, 2018

Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva® Tablets

Jan 29, 2018

Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease

Jan 29, 2018

Mylan and Biocon Receive Positive CHMP Opinion for Semglee™, Biosimilar Insulin Glargine

Jan 09, 2018

Mylan Completes $1 Billion Share Repurchase Plan

Jan 08, 2018

Mylan to Complete $1 Billion Share Repurchase Plan

Jan 03, 2018

Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept)

Dec 29, 2017

Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace® Cream

Pagination

First page
Previous page
…
Page 12
Page 13
Page 14
Page 15
Current page 16
Page 17
Page 18
Page 19
Page 20
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.